Cardlytics
CDLX
111 hedge funds and large institutions have $99.2M invested in Cardlytics in 2024 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 38 increasing their positions, 33 reducing their positions, and 30 closing their positions.
90% more call options, than puts
Call options by funds: $5M | Put options by funds: $2.64M
15% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 33
0.73% less ownership
Funds ownership: 6.93% → 6.19% (-0.73%)
13% less funds holding
Funds holding: 127 → 111 (-16)
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
50% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 30
66% less capital invested
Capital invested by funds: $288M → $99.2M (-$189M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$2.69M |
| 2 |
RC
RBF Capital
San Francisco,
California
|
+$2.05M |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.97M |
| 4 |
PIP
PB Investment Partners
Burlingame,
California
|
+$1.67M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$10M |
| 2 |
TGM
Tenzing Global Management
San Francisco,
California
|
-$5.13M |
| 3 |
DKCM
Davidson Kempner Capital Management
New York
|
-$4.5M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$2.77M |
| 5 |
BCP
Berylson Capital Partners
Boston,
Massachusetts
|
-$2.02M |
CDLX Hedge Fund Activity: Q3 2024 in Review
111 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q3 2024, worth a combined $99.2M — down 66% from $288M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of CDLX and 15 opened new positions — a net loss of 15 holders — while 33 trimmed existing stakes and 38 added.
The largest buyer was D.E. Shaw & Co, adding an estimated $2.69M. The largest seller was Morgan Stanley, cutting an estimated $10M.
- 111 institutional investors held Cardlytics (CDLX) as of Q3 2024, down from 127 in Q2 2024.
- Funds reported $99.2M of Cardlytics stock for Q3 2024, down 66% quarter-over-quarter.
- 15 funds opened new Cardlytics positions in Q3 2024 and 30 closed out, a net change of -15 holders.
- The largest Cardlytics buyer in Q3 2024 was D.E. Shaw & Co, an estimated $2.69M added.
- The largest Cardlytics seller in Q3 2024 was Morgan Stanley, an estimated $10M sold.
Based on aggregated 13F filings for Q3 2024.